Composition for modulating stem cell growth with prostaglandins

Details for Australian Patent Application No. 2009216067 (hide)

Owner Sucampo AG

Inventors Ueno, Ryuji; Kuno, Sachiko

Agent Davies Collison Cave

Pub. Number AU-A-2009216067

PCT Pub. Number WO2009/104807

Priority 61/029,713 19.02.08 US

Filing date 19 February 2009

Wipo publication date 27 August 2009

International Classifications

A61K 31/5575 (2006.01)

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/104807 Priority application(s): WO2009/104807

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009216073-Method of converting solar heat energy

2009216062-Novel aminopyridine derivatives having aurora A selective inhibitory action